In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Encore Medical acquires Empi for about $362.4mm

Executive Summary

Encore Medical (orthopedic devices) has agreed to acquire Empi (a device company specializing in pain management, orthopedic rehab, and physical therapy) for just over $362mm, of which $325mm is in cash and the remainder in 8mm shares of Encore common stock (currently valued at $37.4mm).
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Rehabilitation Equipment and Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register